These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19232964)

  • 1. The use of ertapenem for the treatment of lower extremity infections.
    Nielsen MD; Mendicino RW; Catanzariti AR
    J Foot Ankle Surg; 2009; 48(2):135-41. PubMed ID: 19232964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
    Arguedas A; Cespedes J; Botet FA; Blumer J; Yogev R; Gesser R; Wang J; West J; Snyder T; Wimmer W;
    Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ertapenem: a new opportunity for outpatient parenteral antimicrobial therapy.
    Tice AD
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii83-6. PubMed ID: 15150187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: ertapenem for complicated intra-abdominal infections.
    Falagas ME; Peppas G; Makris GC; Karageorgopoulos DE; Matthaiou DK
    Aliment Pharmacol Ther; 2008 May; 27(10):919-31. PubMed ID: 18266994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians.
    Nix DE; Majumdar AK; DiNubile MJ
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii23-8. PubMed ID: 15150180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ertapenem: a review of its use in the treatment of bacterial infections.
    Keating GM; Perry CM
    Drugs; 2005; 65(15):2151-78. PubMed ID: 16225376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ertapenem: a review of its use in the management of bacterial infections.
    Curran M; Simpson D; Perry C
    Drugs; 2003; 63(17):1855-78. PubMed ID: 12921489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complicated infections of skin and skin structures: when the infection is more than skin deep.
    DiNubile MJ; Lipsky BA
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii37-50. PubMed ID: 15150182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue pharmacokinetics of ertapenem at steady-state in diabetic patients with leg infections.
    Sauermann R; Burian B; Burian A; Jäger W; Höferl M; Stella A; Theurer S; Riedl M; Zeitlinger M
    J Antimicrob Chemother; 2013 Apr; 68(4):895-9. PubMed ID: 23212112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients.
    Yellin AE; Johnson J; Higareda I; Congeni BL; Arrieta AC; Fernsler D; West J; Gesser R
    Am J Surg; 2007 Sep; 194(3):367-74. PubMed ID: 17693284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ertapenem usage in cancer patients with and without neutropenia: a report on 97 cases from a comprehensive cancer center.
    Nesher L; Tverdek FP; Mahajan SN; Chemaly RF; Rolston KV
    Infection; 2015 Oct; 43(5):545-50. PubMed ID: 25929421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy.
    Goldstein EJ; Snydman DR
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii29-36. PubMed ID: 15150181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of ertapenem for consolidation therapy of extended-spectrum beta-lactamase-producing gram-negative infections: a case series report.
    Berg ML; Crank CW; Philbrick AH; Hayden MK
    Ann Pharmacother; 2008 Feb; 42(2):207-12. PubMed ID: 18230703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ertapenem for the treatment of extended-spectrum beta-lactamase-producing Gram-negative bacterial infections.
    Teng CP; Chen HH; Chan J; Lye DC
    Int J Antimicrob Agents; 2007 Oct; 30(4):356-9. PubMed ID: 17631986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis.
    Lauf L; Ozsvár Z; Mitha I; Regöly-Mérei J; Embil JM; Cooper A; Sabol MB; Castaing N; Dartois N; Yan J; Dukart G; Maroko R
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):469-80. PubMed ID: 24439136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes with ertapenem as a first-line treatment option of infections caused by extended-spectrum β-lactamase producing gram-negative bacteria.
    Fong JJ; Rosé L; Radigan EA
    Ann Pharmacother; 2012 Mar; 46(3):347-52. PubMed ID: 22395250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies.
    Bassetti M; Eckmann C; Bodmann KF; Dupont H; Heizmann WR; Montravers P; Guirao X; Capparella MR; Simoneau D; Sánchez García M
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii5-14. PubMed ID: 23772047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
    BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.